Scholarlink

Background <p>Radiation resistance remains a clinical challenge in the treatment of triple-negative breast cancer (TNBC) and its mechanisms are not yet fully understood.</p> Methods <p>We integrated single-cell RNA sequencing, spatial transcriptomics, and prognostic data to perform analyses such as intercellular communication, pseudo-temporal trajectories, and GSEA and validated the results using experiments including qPCR, single-cell sequencing and flow cytometry.</p> Results <p>This study identified a unique subpopulation of epithelial cells, designated TOPBP1⁺ E.T. cells, which retain normal epithelial transcriptional profiles and are associated with poor patient prognosis. myCAF communicates with this cell cluster via the THBS1 signaling pathway, activating the NOTCH signaling pathway to promote resistance to radiotherapy.</p> Conclusions <p>THBS1 plays a pivotal role in mediating radioresistance in triple-negative breast cancer, positioning it as a promising therapeutic target.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Single-cell and spatial transcriptomics reveal that THBS1 induces radiation resistance in TNBC through the interaction between myCAF and TOPBP1⁺ tumor cells

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月24日

查看全文
  • Fuzhong Liu,
  • Xing Xu,
  • Wenhao Tong,
  • Yang Xie,
  • Yecheng Ma,
  • Lingling Yang,
  • Xun Jin

摘要

Background

Radiation resistance remains a clinical challenge in the treatment of triple-negative breast cancer (TNBC) and its mechanisms are not yet fully understood.

Methods

We integrated single-cell RNA sequencing, spatial transcriptomics, and prognostic data to perform analyses such as intercellular communication, pseudo-temporal trajectories, and GSEA and validated the results using experiments including qPCR, single-cell sequencing and flow cytometry.

Results

This study identified a unique subpopulation of epithelial cells, designated TOPBP1⁺ E.T. cells, which retain normal epithelial transcriptional profiles and are associated with poor patient prognosis. myCAF communicates with this cell cluster via the THBS1 signaling pathway, activating the NOTCH signaling pathway to promote resistance to radiotherapy.

Conclusions

THBS1 plays a pivotal role in mediating radioresistance in triple-negative breast cancer, positioning it as a promising therapeutic target.

Graphical Abstract